ASMLs, China

ASML's China Conundrum: A 1.4-Billion-Euro Question Wrapped in a 30% Capacity Answer

Published on 08/09/2026 at 02:51 | Redaktion boerse-global.de

Despite China's Aiscent assembling DUV tools, ASML's scale, orders, and raised guidance fuel a 5.94% share recovery, easing fears.

ASML Stock Rebounds as Investors Reassess China Lithography Threat
ASML Holding Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

The numbers tell a story that the headlines often miss. When reports surfaced in late July that Shanghai Aiscent Electronic Technology Group had begun assembling immersion DUV lithography systems — the workhorse machines that have generated billions for ASML — the Dutch giant's shares shed as much as 8 percent, touching their lowest level since early June. Yet by Friday's close, the stock had clawed back to €1,508.20, a 5.94 percent advance over seven trading days. The recovery suggests investors haven't dismissed the Chinese threat so much as they've recalculated its dimensions.

That recalculation hinges on a deceptively simple question: can a Chinese manufacturer move from building a handful of prototype machines to delivering them at industrial scale with reliable yields? According to the reports, Aiscent — which has reportedly absorbed teams from Yuliangsheng, a Huawei-affiliated offshoot of SiCarrier, and Shanghai Micro Electronics Equipment (SMEE) — targets just five units this year and roughly twenty by 2027. ASML, by contrast, plans to ship around 130 comparable DUV systems in the current year alone.

The gap between those figures is where the bull case lives. BNP Paribas Exane analyst Scemama has crunched the scenario: even if China sourced twenty domestically produced systems next year, the impact on ASML's revenue would be roughly €1.4 billion — about 2.4 percent of the group's expected total sales. Sandeep Deshpande, another analyst, framed the challenge more bluntly: producing a handful of immersion DUV tools is not the same as producing tools capable of high-volume manufacturing. Yield rates, overlay precision, throughput and reliability across thousands of wafer runs remain formidable hurdles.

The company's own numbers reinforce that confidence. Second-quarter results showed net sales of €9.3 billion, a gross margin of 54.0 percent and net income of €2.9 billion. Management guided third-quarter sales to between €11.0 billion and €12.0 billion with gross margin of 55 to 57 percent. The full-year 2026 forecast now stands at €43 billion to €45 billion — the second upward revision this year. CEO Christophe Fouquet described first-half order intake as "extremely strong," noting that customers are accelerating capacity plans with firm commitments across the product portfolio.

Should investors sell immediately? Or is it worth buying ASML Holding?

That demand is driving an aggressive expansion program. ASML plans to boost manufacturing capacity for low-NA EUV and DUV immersion systems by roughly 30 percent in 2027 versus 2026, with another expansion phase under consideration for 2028. The company also repurchased approximately €1.1 billion of its own shares in the second quarter and paid an interim dividend of €1.88 per share on August 5. The order book for next-generation EUV machines is reportedly sold out through the end of 2027.

Wall Street has taken notice. Goldman Sachs added ASML to its European Conviction List in late July, citing growing visibility on capacity expansion backed by strong order intake across both logic and DRAM segments. The bank's earnings estimates for fiscal 2027 through 2029 run 5 to 18 percent above consensus. Bernstein went further, reaffirming an "Outperform" rating with a €2,500 price target and naming ASML one of its top ideas for the third quarter. Several other houses had already lifted targets above €2,100 following the Q2 print.

The bear case, however, isn't purely hypothetical. China still accounted for 14 percent of ASML's system sales in the second quarter — roughly €924 million — down from 19 percent previously. A continued decline, driven by domestic substitution, would dent the growth narrative even if the absolute financial impact remains contained. ODDO BHF's Stephane Houri cautioned that Chinese progress may be limited to lower-performance segments — a reassuring read, but hardly a guarantee.

The political dimension adds another layer of complexity. The Shanghai report landed just as the US Congress advances the MATCH Act, legislation designed to block the sale and servicing of precisely these DUV machines to China. If Beijing succeeds in building its own, Washington's planned restrictions lose their teeth. The sell-off also rippled beyond ASML: South Korea's KOSPI index lost roughly 10 percent at one point, while the SOX semiconductor index has underperformed the S&P 500 significantly from its peak. ASML's share price sits 23.82 percent above its 200-day moving average — a stretched position that leaves room for pullbacks on any disappointing news.

ASML Holding at a turning point? This analysis reveals what investors need to know now.

SemiAnalysis analysts argue the real bottleneck for China isn't building a prototype but scaling mass production complete with the surrounding ecosystem — in their view, the most underestimated factor in the entire debate. Bank of America, for its part, classified the Chinese threat as "moderate."

The next test arrives with third-quarter results, expected around mid-October. By then, investors will have a clearer picture of whether the second guidance raise holds and whether the order momentum that underpins ASML's capacity expansion remains intact. For now, the China question appears more likely to weigh on the stock's valuation than on its business model — provided the order book stays full and the 2027-2028 expansion plans proceed as promised.

Ad

ASML Holding Stock: New Analysis - 9 August

Fresh ASML Holding information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated ASML Holding analysis...

Disclaimer...

en | NL0010273215 | ASMLS | boerse | 69928945 |